Early access treatment is an override mechanism that allows patients to access new treatments that are not yet approved (pre-MAM early access) or not yet reimbursed (post-MAM early access). These treatments may be an additional treatment option for cancer patients.

Neo-adjuvant therapy : Neoadjuvant therapy is a type of treatment used to treat cancer before surgery. Most often, the aim of neoadjuvant therapy is to reduce the size of the tumor before surgery.

Adjuvant therapy : Adjuvant therapy is a type of treatment that is used after surgery to treat cancer.

Neoadjuvant and adjuvant therapy may include:

• Chemotherapy
• radiation therapy
• immunotherapy
• hormonal therapy

There are other treatments available through clinical trials

With Klineo, you can find the clinical trials that are right for you. To do this, it is important to enter the treatments received in order to find relevant clinical trials. This information can be found in the recent consultation report.

Treatments used to treat metastatic cancer are called “processing lines”. A treatment line may include:

• Chemotherapy
• Radiotherapy
• Immunotherapy
• Targeted therapy

Example:

• If treatment with surgery + adjuvant chemotherapy, then surveillance and metastatic relapse - then 0 treatment lines should be entered at the metastatic stage.
• If treatment by surgery + chemotherapy as an adjuvant, then surveillance and metastatic relapse with a 1st line of chemotherapy treatment, then stop because of new progression, then 1 line of treatment and the name of the chemotherapy must be entered.

There are other treatments available through clinical trials.

With Klineo, you can find the clinical trials that are right for you. To do this, it is important to enter the treatments received in order to find relevant clinical trials. This information can be found in the recent consultation report.